Hong Kong stock trading anomaly | WuXi AppTec B(02126.HK) rose more than 10%, operating profit decrease in the first half of the year is good, additional disclosure of CD19/20 dual-target CAR-T pipeline.

According to the Securities Times APP, Wuhan Biotechnology Ltd-B (02126.HK) surged over 10% in the afternoon, as of the time of publication, it increased by 8.42% to 5.41 Hong Kong dollars, with a trading volume of 26.336 million Hong Kong dollars.